Oncology
WHA 2026: WHO resolution moves precision medicine onto the global health policy agenda
At the Seventy-ninth World Health Assembly, Member States endorsed a new resolution on precision medicine. On paper, that may sound like another technical step in global health diplomacy. It is not.
Liquid Biopsy Turns Precision Oncology Into an NHS Delivery Test
Molecular Testing Is Europe’s Real Precision Oncology Infrastructure
Cancer Approval Is No Longer Enough
Europe’s Cancer Inequality Map Becomes a Performance Test
Europe’s Cancer Projects Start Looking Like Delivery Infrastructure
EU Cancer Policy Moves Back Into Budget Politics
Genomic Matching Works When the Evidence Is Strong Enough to Act
England’s Cancer Plan Turns Personalised Care Into a National Delivery Test
Cancer Drugs Put Europe’s New HTA System to Its First Real Test
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.